🔥 Hot topics · KAN IKKE · Kan · § The Court · Seneste omvendinger · 📈 Tidslinje · Spørg · Ledere · 🔥 Hot topics · KAN IKKE · Kan · § The Court · Seneste omvendinger · 📈 Tidslinje · Spørg · Ledere
Stuff AI CAN'T Do

Kan AI designe et lægemiddelstof, der binder til et specifikt proteinmål uden tidligere eksperimentelle data ?

Hvad mener du?

Traditionelt set er lægemiddelforskning afhængig af omfattende laboratorieeksperimenter og gentagne tests for at identificere levedygtige forbindelser. Nylige AI-modeller, såsom dem, der anvender diffusionsbaserede generative tilgange, kan nu foreslå nye molekylære strukturer skræddersyet til specifikke biologiske mål. Denne evne fremskynder de tidlige faser af farmaceutisk forskning og reducerer afhængigheden af systematisk screening.

Background

Traditionally, drug discovery relies on extensive lab experiments and iterative testing to identify viable compounds. Recent AI models, such as those using diffusion-based generative approaches, can now propose novel molecular structures tailored to specific biological targets. This capability accelerates the early stages of pharmaceutical research and reduces reliance on brute-force screening.

AI can propose novel drug-like compounds that bind a specified protein target even when no prior experimental data exist, using structure-based deep learning methods such as RFdiffusion or diffusion models trained on protein-ligand complexes to generate chemically plausible molecules and docking scores without wet-lab feedback. These generative models learn the rules of molecular binding from large structural databases and propose candidates that fit the target’s binding pocket, though their designs still require downstream biochemical validation to confirm affinity, selectivity, and drug-like properties (Nature, Enriched May 12, 2026).

The latest systems integrate evolutionary search or reinforcement learning to refine potency and ADMET (absorption, distribution, metabolism, excretion, and toxicity) profiles, increasing the fraction of synthetically accessible, high-scoring hits that can enter experimental testing. Because no 3D structure is strictly necessary, sequence-based models like AlphaFold-informed pocket predictions can also guide ligand design when an experimental structure is unavailable.

Status senest tjekket July 3, 2026.

📰

Galleri

In the Court of AI Capability
Summary of Findings
Verdict over time
May 2026May 2026May 2026May 2026May 2026Jun 2026Jun 2026Jun 2026Jun 2026Jun 2026Jul 2026
Sitting at the Bench Filed · jul. 3, 2026
— The Question Before the Court —

Kan AI designe et lægemiddelstof, der binder til et specifikt proteinmål uden tidligere eksperimentelle data?

★ The Court Finds ★
▼ Downgraded from Ja
Næsten

Snævre demoer findes — men panelet var ikke enigt.

Ruling of the Bench

The jury found that today’s AI can draft novel drug-like molecules with uncanny speed, yet each promising design still demands a lab’s sober gaze before it may be called medicine. Their near-unanimous vote reflected enthusiasm for the algorithmic spark and cautious respect for the experimental fire that must follow. Ruling: “AI can sketch the molecule, but the body gets veto power.”

— Hon. D. Knuth-Hale, Presiding
Jury Tally
0Ja
3Næsten
0Nej
Verdict Confidence
85%
The Court of AI Capability is, of course, not a real court.
But the data is real.
The Case File · Stacked History
Session I · May 2026 In_research
Session II · May 2026 Næsten · 83%
Session III · May 2026 Næsten · 82%
Session IV · May 2026 Næsten · 77%
Session V · May 2026 Næsten · 77%
Session VI · Jun 2026 Næsten · 78%
Session VII · Jun 2026 Næsten · 77%
Session VIII · Jun 2026 Næsten · 85%
Session IX · Jun 2026 Næsten · 90%
Session X · Jun 2026 Ja · 95%
Case № C989 · Session XI
In the Court of AI Capability

The Case File

Docket № C989 · Session XI · Vol. XI
I. Particulars of the Case
Question put to the courtKan AI designe et lægemiddelstof, der binder til et specifikt proteinmål uden tidligere eksperimentelle data?
SessionXI (11 hearing)
Convened3 jul. 2026
Previously ruledIN_RESEARCH (May '26) → ALMOST (May '26) → ALMOST (May '26) → ALMOST (May '26) → ALMOST (May '26) → ALMOST (Jun '26) → ALMOST (Jun '26) → ALMOST (Jun '26) → ALMOST (Jun '26) → YES (Jun '26) → ALMOST (Jul '26)
Presiding JudgeHon. D. Knuth-Hale
II. Cumulative Tally Across Sessions

Across 11 sessions, 29 jurors have heard this case. Combined tally: 11 YES · 17 ALMOST · 1 NO · 0 IN RESEARCH.

Note: cumulative includes older juror opinions. The current session tally above is the live verdict.

III. Verdict

By a vote of 0 — 3 — 0, the panel returns a verdict of NæSTEN, with verdict confidence of 85%. The court so orders. Verdict downgraded from prior session.

IV. Udtalelser fra dommerpanelet
Nævning I ALMOST

"AI can generate compounds, but accuracy varies"

Nævning II ALMOST

"Multiple AI systems generate candidate compounds but require experimental validation"

Nævning III ALMOST

"AI can generate compounds but requires validation"

Individuelle nævningers udtalelser vises på originalengelsk for at bevare bevismæssig præcision.

D. Knuth-Hale
Presiding Judge
M. Lovelace
Clerk of the Court

Hvad publikum mener

Nej 30% · Ja 39% · Måske 30% 23 votes
Nej · 30%
Ja · 39%
Måske · 30%
56 days of activity

Diskussion

no comments

Kommentarer og billeder gennemgår admin-godkendelse før de vises offentligt.

11 jury checks · seneste for 23 timer siden
03 Jul 2026 3 jurors · uafklaret, uafklaret, uafklaret uafklaret
27 Jun 2026 1 juror · kan kan
22 Jun 2026 1 juror · uafklaret uafklaret
17 Jun 2026 4 jurors · uafklaret, kan, kan, uafklaret uafklaret
11 Jun 2026 3 jurors · uafklaret, uafklaret, uafklaret uafklaret
06 Jun 2026 3 jurors · uafklaret, kan, uafklaret uafklaret
31 May 2026 2 jurors · kan, uafklaret uafklaret
26 May 2026 2 jurors · kan, uafklaret uafklaret
21 May 2026 3 jurors · uafklaret, kan, uafklaret uafklaret
15 May 2026 4 jurors · kan, kan, uafklaret, uafklaret uafklaret
12 May 2026 3 jurors · kan, kan ikke, kan uafklaret

Hver række er et separat jurytjek. Nævninger er AI-modeller (identiteter holdt neutrale med vilje). Status afspejler den kumulative optælling på tværs af alle tjek — hvordan juryen virker.

Flere i health

Har du en vi gik glip af?

Tilføj et udsagn til atlasset. Vi gennemgår ugentligt.